Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Singapore fast-tracks medtech innovation with first regulatory reliance pilot, says GlobalData

Singapore medical device sector is set for a transformative shift with the launch of the first regulatory reliance pilot, a landmark collaboration between Singapore’s Health Science Authority (HSA) and Malaysia’s Medical Devices Authority (MDA) that promises to accelerate access to advanced medical technologies across the region. These efforts will further solidify Singapore’s reputation as a […]
Read more

Edwards Lifesciences’ TAVR growth continues as market accelerates, says GlobalData

The global transcatheter aortic valve replacement (TAVR) market is growing rapidly in both developed and emerging markets. The market is poised for substantial expansion over the next decade, reflecting both demographic trends and clinical innovation. Edwards Lifesciences has established itself as the global leader in the TAVR market. The company reported an 8.9% year-over-year (YoY) […]
Read more

South Korea polymerase chain reaction systems market to grow at 4% CAGR through 2034, forecasts GlobalData

With the rise of emerging infectious diseases in South Korea, the importance of advanced diagnostics is becoming increasingly evident. Consequently, South Korea’s polymerase chain reaction (PCR) systems market is expected to experience a 4% compound annual growth rate (CAGR) through 2034, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Polymerase Chain Reaction (PCR) Systems Market Size […]
Read more

PET agents gain momentum as SPECT holds strong in nuclear medicine, says GlobalData

Though single-photon emission computed tomography (SPECT) remains the dominant modality for nuclear imaging globally, positron emission tomography (PET) imaging is gaining momentum, particularly in oncology and other high-value applications, primarily driven by tracer innovation, says GlobalData, a leading data and analytics company. According to GlobalData’s recently updated “Nuclear Imaging Agents” market model, the global PET […]
Read more

Singapore embraces AI to transform pulmonary care landscape, says GlobalData

Singapore is accelerating its position as a regional leader in advanced healthcare with the adoption of AI-powered intraoperative imaging technologies for pulmonary care. The recent regulatory approval of innovative platforms designed to enhance the early detection of lung cancer marks a pivotal step toward improving diagnostic accuracy, facilitating timely interventions, and strengthening patient outcomes in […]
Read more

Zimmer and Stryker intensify rivalry as US knee reconstruction market tops $400 million in Q2 2025, reveals GlobalData

The US knee reconstruction market surpassed $400 million in the second quarter (Q2) of 2025, with innovation and pricing strategies reshaping competitive dynamics. While Zimmer Biomet retains the lead, Stryker’s momentum signals a potential power shift. As patient demand for advanced implants rises, market leadership will hinge on technological sophistication and clinical outcomes rather than […]
Read more

FTC challenge to Edwards Lifesciences’ JenaValve acquisition to delay TAVR-AR device approvals, says GlobalData

The US Federal Trade Commission (FTC) recently announced its intention to block Edwards Lifesciences’ acquisition of JenaValve, a medical device company focusing on transcatheter aortic valve replacement for aortic regurgitation (TAVR-AR). The initial complaint brought against Edwards Lifesciences by the FTC includes concerns over competitive dynamics for the TAVR-AR market, as JenaValve and Edwards Lifesciences’ […]
Read more

SetPoint Medical’s funding highlights investor confidence in neuromodulation approaches for autoimmune conditions, says GlobalData

SetPoint Medical has recently secured $140 million in private financing to advance the commercial rollout of its SetPoint System, marking a major milestone in neuroimmune therapy for rheumatoid arthritis (RA). This funding underscores strong investor confidence in pioneering neuromodulation approaches to treating chronic autoimmune conditions, says GlobalData, a leading data and analytics company. The SetPoint […]
Read more

Australia X-ray systems market to expand at 4% CAGR through 2036, forecasts GlobalData

Australia’s medical imaging landscape is undergoing a transformative shift as artificial intelligence (AI) redefines diagnostic accuracy in chest X-rays. By integrating clinical data with imaging, AI is enabling earlier detection of diseases such as pneumonia, lung cancer, and tuberculosis. Against this backdrop, the X-ray systems market in Australia is anticipated to grow at a compound […]
Read more

Thermo Fisher’s FDA approval for NGS-based companion diagnostic to advance personalization of lung cancer treatment, says GlobalData

The US Food and Drug Administration (FDA) has granted accelerated approval to HERNEXEOS (zongertinib)-a HER2 selective tyrosine kinase inhibitor- for adults with previously treated, unresectable or metastatic non-small cell lung cancer (NSCLC) harboring HER2 tyrosine kinase domain activating mutations. Simultaneously, the FDA approved Thermo Fisher’s Oncomine Dx Target Test as the companion diagnostic (CDx) to […]
Read more

North America capsule endoscopy market to register 6.2% CAGR over 2024-34, forecasts GlobalData

Capsule endoscopy is a non-invasive approach that aids healthcare providers in diagnosing conditions such as gastrointestinal bleeding, Barrett’s oesophagus, inflammatory bowel disease (IBD), and other gastrointestinal disorders. Driven by growing demand for minimally invasive procedures, the capsule endoscopy market in North America is set to experience steady growth, registering a compound annual growth rate (CAGR) […]
Read more

ICP monitoring devices market grows modestly amid clinical reliance, limited innovation and access gaps, finds GlobalData

Intracranial pressure (ICP) monitoring devices remain essential in managing neurological emergencies, yet the market is maturing slowly amid limited innovation and entrenched clinical preferences. With annual growth at just 2.4%, the sector is shaped more by procedural reliability than technological disruption. Despite their proven value, broader adoption hinges on integrating innovation with clinical workflows and […]
Read more

Evolving EU, UK regulations challenge medical device firms to adapt market entry strategies, says GlobalData

The medical device industry is confronting a rapidly shifting regulatory landscape shaped by recent reforms in the EU and UK. With heightened scrutiny, stricter compliance requirements, and centralized oversight, manufacturers must adapt swiftly. These developments are reshaping market entry strategies, influencing innovation timelines, and compelling companies to reassess operational agility to maintain competitiveness and ensure […]
Read more

South Korea immunochemistry analyzers market to grow at 4% CAGR through 2036, forecasts GlobalData

Driven by the rising demand for advanced diagnostics, technological advancements, and aging population, the market for immunochemistry analyzers in South Korea is expected to expand at a compound annual growth rate (CAGR) of 4% between 2025 and 2036, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Immunochemistry Analyzers Market Size by Segments, Share, […]
Read more
1 2 3 4 5 6 … 50